Dr. Catherine Cuite, M.D
NPI: 1679560221
Total Payments
$722.20
2024 Payments
$84.05
Companies
9
Transactions
21
Medicare Patients
3,160
Medicare Billing
$432,328
Payment Breakdown by Category
Food & Beverage$500.20 (69.3%)
Other$222.00 (30.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $500.20 | 18 | 69.3% |
| Entertainment | $207.89 | 2 | 28.8% |
| Debt forgiveness | $14.11 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $224.38 | 7 | $0 (2022) |
| OPTOS, INC. | $207.89 | 2 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $65.00 | 1 | $0 (2018) |
| Amgen Inc. | $59.19 | 3 | $0 (2024) |
| Allergan, Inc. | $57.26 | 3 | $0 (2022) |
| ABBVIE INC. | $49.44 | 2 | $0 (2024) |
| Alcon Vision LLC | $24.85 | 1 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $20.08 | 1 | $0 (2019) |
| Welch Allyn | $14.11 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.05 | 4 | Amgen Inc. ($59.19) |
| 2023 | $24.58 | 1 | AbbVie Inc. ($24.58) |
| 2022 | $90.92 | 5 | Horizon Therapeutics plc ($44.42) |
| 2021 | $36.97 | 2 | Horizon Therapeutics plc ($22.86) |
| 2020 | $180.51 | 4 | Horizon Therapeutics plc ($157.10) |
| 2019 | $240.17 | 4 | OPTOS, INC. ($207.89) |
| 2018 | $65.00 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($65.00) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.86 | General |
| 06/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/13/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $24.58 | General |
| 11/23/2022 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Ophthalmology | ||||||
| 10/10/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: TEPEZZA | ||||||
| 09/09/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: TEPEZZA | ||||||
| 08/30/2022 | Allergan, Inc. | — | Food and Beverage | In-kind items and services | $21.65 | General |
| 07/20/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: TEPEZZA | ||||||
| 11/23/2021 | Welch Allyn | None (Device) | Debt forgiveness | Cash or cash equivalent | $14.11 | General |
| Category: Not Applicable | ||||||
| 02/23/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: TEPEZZA | ||||||
| 09/09/2020 | Allergan, Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| 03/12/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | Cash or cash equivalent | $125.60 | General |
| Category: TEPEZZA | ||||||
| 02/05/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: TEPEZZA | ||||||
| 01/15/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: TEPEZZA | ||||||
| 12/10/2019 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: Ophthalmology | ||||||
| 10/29/2019 | OPTOS, INC. | P200DTx (Device), P200T, P200TE | Entertainment | Cash or cash equivalent | $102.23 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/08/2019 | OPTOS, INC. | P200DTx (Device), P200T, P200TE | Entertainment | Cash or cash equivalent | $105.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2019 | Allergan Inc. | BOTOX COSMETIC (Biological) | Food and Beverage | In-kind items and services | $12.20 | General |
| 01/15/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 918 | 3,775 | $432,779 | $125,523 |
| 2022 | 15 | 805 | 2,839 | $348,685 | $107,039 |
| 2021 | 13 | 711 | 2,182 | $317,551 | $100,026 |
| 2020 | 12 | 726 | 2,193 | $337,089 | $99,741 |
Total Patients
3,160
Total Services
10,989
Medicare Billing
$432,328
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 295 | $74,346 | $25,794 | 34.7% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 30 | 30 | $69,384 | $17,960 | 25.9% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 27 | 28 | $66,458 | $16,699 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 230 | $40,713 | $13,930 | 34.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 28 | 2,628 | $25,920 | $12,523 | 48.3% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 31 | 70 | $24,804 | $7,703 | 31.1% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 41 | 47 | $17,178 | $5,080 | 29.6% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2023 | 18 | 18 | $23,220 | $5,040 | 21.7% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 23 | 23 | $13,656 | $4,870 | 35.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 90 | 90 | $14,040 | $3,939 | 28.1% |
| 67900 | Repair of brow paralysis | Facility | 2023 | 14 | 14 | $28,405 | $3,686 | 13.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $8,829 | $2,452 | 27.8% |
| 67924 | Extensive repair of turning-inward eyelid defect | Facility | 2023 | 11 | 11 | $13,332 | $2,258 | 16.9% |
| 92285 | Photography of content of eyes | Office | 2023 | 92 | 98 | $4,254 | $1,471 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $5,014 | $1,214 | 24.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 20 | 22 | $2,621 | $810.86 | 30.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 121 | $605.00 | $92.78 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 242 | $60,984 | $22,002 | 36.1% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 32 | 32 | $74,088 | $18,212 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 192 | 245 | $43,365 | $16,109 | 37.1% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 24 | 25 | $65,044 | $15,737 | 24.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 20 | 1,939 | $12,394 | $9,264 | 74.7% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 21 | 22 | $12,121 | $4,577 | 37.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 93 | 95 | $14,820 | $4,266 | 28.8% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 20 | 43 | $12,600 | $4,089 | 32.4% |
About Dr. Catherine Cuite, M.D
Dr. Catherine Cuite, M.D is a Ophthalmic Plastic and Reconstructive Surgery healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679560221.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Cuite, M.D has received a total of $722.20 in payments from pharmaceutical and medical device companies, with $84.05 received in 2024. These payments were reported across 21 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($500.20).
As a Medicare-enrolled provider, Cuite has provided services to 3,160 Medicare beneficiaries, totaling 10,989 services with total Medicare billing of $432,328. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmic Plastic and Reconstructive Surgery
- Other Specialties Ophthalmology
- Location Charlotte, NC
- Active Since 09/29/2005
- Last Updated 04/28/2021
- Taxonomy Code 207WX0200X
- Entity Type Individual
- NPI Number 1679560221
Products in Payments
- TEPEZZA (Drug) $224.38
- P200DTx (Device) $207.89
- VYZULTA (Drug) $65.00
- TEPEZZA (Biological) $59.19
- BOTOX COSMETIC (Biological) $35.61
- Clareon (Device) $24.85
- CEQUA (Drug) $20.08
- None (Device) $14.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.